EP3892284
COMBINATION OF A PD-1 ANTAGONIST AND A CPG-C TYPE OLIGONUCLEOTIDE FOR TREATING CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.5.2016EP published:
22.5.2024EP application number:
21159163.1
EPO information:
European Patent Register
Max expiry date:
25.5.2036
Title in English:
COMBINATION OF A PD-1 ANTAGONIST AND A CPG-C TYPE OLIGONUCLEOTIDE FOR TREATING CANCERLanguage of the patent:
English
Timeline
Today
26.5.2016EP application
22.5.2024EP Publication
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
Name:
TriSalus Life Sciences, Inc.Address:
6272 West 91st Avenue, Westminster, CO 80031, US
Inventor
Name:
YU, YingAddress:
Palo Alto, CA California 94304, US
Name:
DENKER, Andrew EvanAddress:
Ardmore, PA Pennsylvania 19003, US
Name:
SADEKOVA, SvetlanaAddress:
Palo Alto, CA California 94304, US
Name:
PHAN, Uyen TruongAddress:
Palo Alto, CA California 94304, US
Name:
KASTELEIN, Robert A.Address:
Palo Alto, CA California 94304, US
Name:
KAUFMAN, David RossAddress:
North Wales, PA Pennsylvania 19454, US
Name:
COFFMAN, Robert L.Address:
Berkeley, CA California 94710-2753, US
Name:
GUIDUCCI, CristianaAddress:
Berkeley, CA California 94710-2753, US
Name:
JANSSEN, Robert S.Address:
Berkeley, CA California 94710-2753, US
Priority
Number:
201562168449 PDate:
29.5.2015Country:
US
Number:
201562169309 PDate:
1.6.2015Country:
US
Classification
Categories:
A61K 31/7125, A61K 31/713, A61P 35/00, A61P 35/04, A61K 9/00, A61K 39/39, A61N 5/00, C07K 14/435